Salivary tests for oral cancer stay in research; examination and biopsy stay the standard

Design

Living evidence-informed guideline using GRADE evidence-to-decision framework

Population

Adults with and without oral mucosal or lip abnormalities

Primary outcome

Recommendations on salivary adjunct tests for early oral cancer detection

Effect

Research-only recommendations for both uses; oral examination for all adults; biopsy or referral for persistent lesions

A US living guideline, built on a continuously updated systematic review and a GRADE evidence-to-decision process, assessed commercially available salivary adjunct tests for oral squamous cell carcinoma and potentially malignant disorders. It considered two uses: screening adults with no visible lesion, and deciding whether an adult with a visible mucosal abnormality needs a biopsy.

The panel made research-only recommendations for both uses: the tests should not be used in routine practice or public screening outside studies. It added good practice statements that every adult should have a clinical oral examination, and that a persistent mucosal abnormality should be biopsied or referred.

For pathologists and the clinicians who send them oral biopsies, the message is that histology remains the reference standard, and a negative salivary test should not stand in for tissue. That matters in India, where oral cancer is common, tobacco and areca nut use are widespread, and commercial tests can appear attractive as a cheaper screen. It was published on 28 September 2026.

• Biopsy or refer any persistent oral mucosal lesion; a salivary test result does not replace tissue.
• Do not use salivary adjunct tests to screen people without lesions outside a research study.
• Include a clinical oral examination for every adult, especially tobacco and areca nut users.
• If a clinician asks about a salivary test result, recommend proceeding on clinical and histological grounds.

Why it matters

A test that falsely reassures could delay the biopsy that finds an early cancer.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.